Who is sponsoring NCT03209284?

NCT03209284 is sponsored by International Piezosurgery Academy.

What drugs are being tested in NCT03209284?

Interventions in NCT03209284: transcrestal sinus floor elevation.

What condition does NCT03209284 study?

NCT03209284 studies Atrophy of Edentulous Maxillary Alveolar Ridge.

Is NCT03209284 still recruiting?

NCT03209284 is currently completed. Last updated 28 August 2019.

Last reviewed 2019-08-28 · How we verify

NCT03209284: SLSS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Influence of Anatomy of Maxillary Sinus on New Bone Formation After Transcrestal Augmentation Procedures

Completed Last updated 28 August 2019

What this trial tests

trial testing transcrestal sinus floor elevation in Atrophy of Edentulous Maxillary Alveolar Ridge in 30 participants. Completed in 15 February 2017.

Timeline

15 July 2014

Primary endpoint
15 September 2015

15 February 2017

Quick facts

Lead sponsor	International Piezosurgery Academy
Status	Completed
Study type	OBSERVATIONAL
Enrollment	30
Start date	15 July 2014
Primary completion	15 September 2015
Estimated completion	15 February 2017
Sites	1 location across Italy

Drugs / interventions tested

transcrestal sinus floor elevation

Conditions studied

Atrophy of Edentulous Maxillary Alveolar Ridge — all drugs for Atrophy of Edentulous Maxillary Alveolar Ridge →

Sponsor

International Piezosurgery Academy

Who can join

18 and older, any sex, with Atrophy of Edentulous Maxillary Alveolar Ridge. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to analyze neoformed bone after maxillary sinus lifting with transcrestal approach, in atrophic crests (≤5 mm residual bone height). Clinical and laboratory data will be related to maxillo breast anatomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of transcrestal sinus floor elevation

Trials testing the same drug.

NCT05305521 — Transcrestal Maxillary Sinus Floor Elevation With Injectable Bone Substitute · completed

Other International Piezosurgery Academy trials

Trials by the same sponsor.

NCT06866431 — Effect Of Cavitation In Post-Extractive Socket Healing · recruiting
NCT06808724 — Clinical Influence of Different Surface Treatments on Implant Stabiity · recruiting
NCT07019480 — Influence of Implant Insertion Torque on Post-Surgical Marginal Bone Stability · active not recruiting
NCT06784232 — Alveolar Ridge Preservation: Biologically-oriented Alveolar Ridge Preservation Vs Modified Periosteal Inhibition · active not recruiting
NCT06679894 — Evaluation of Implant Stability Changes in Sites Prepared with Different Osseodensification Techniques: a Prospective Ob · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03209284 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by International Piezosurgery Academy
Last refreshed: 28 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03209284.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing